Membrane schematic representation

Figure 4.18 In-vivo electron transfer in photosynthetic membranes. Schematic representation of the reaction centre in the chromatophore membrane. The immediate reactants arc cytochrome c molecules (C2) BB is the dimer of bacteriochlorophyll, 1 is bacteriopheophytin, and Q is a quinone. Firom Ref. [48,b].

Several human receptors for the neurohypophyseal hormones have been cloned and the sequences elucidated. The human V2 receptor for antidiuretic hormone presumably contains 371 amino acids and seven transmembrane segments and activates cycHc AMP (76). The oxytocin receptor is a classic G-protein-coupled type of receptor with a proposed membrane topography also involving seven transmembrane components (84). A schematic representation of the oxytocin receptor stmcture within the membrane is shown in Eigure 4 (85). 

Fig. 28. Schematic representation of dead-end and cross-flow filtration with microfiltration membranes. The equipment used in dead-end filtration is simple, but retained particles plug the membranes rapidly. The equipment required for cross-flow filtration is more complex, but the membrane lifetime is...

Fig. 18. Schematic representation of cycling of low density Hpoprotein (LDL) receptors from the plasma membrane to the cell interior.

Figure 7 is a schematic representation of a section of a cascade. The feed stream to a stage consists of the depleted stream from the stage above and the enriched stream from the stage below. This mixture is first compressed and then cooled so that it enters the diffusion chamber at some predetermined optimum temperature and pressure. In the case of uranium isotope separation the process gas is uranium hexafluoride [7783-81-5] UF. Within the diffusion chamber the gas flows along a porous membrane or diffusion barrier. Approximately one-half of the gas passes through the barrier into a region... 

The primary reference method used for measuring carbon monoxide in the United States is based on nondispersive infrared (NDIR) photometry (1, 2). The principle involved is the preferential absorption of infrared radiation by carbon monoxide. Figure 14-1 is a schematic representation of an NDIR analyzer. The analyzer has a hot filament source of infrared radiation, a chopper, a sample cell, reference cell, and a detector. The reference cell is filled with a non-infrared-absorbing gas, and the sample cell is continuously flushed with ambient air containing an unknown amount of CO. The detector cell is divided into two compartments by a flexible membrane, with each compartment filled with CO. Movement of the membrane causes a change in electrical capacitance in a control circuit whose signal is processed and fed to a recorder. 

Figure 15.18 (a) Schematic representation of the path of the polypeptide chain in the structure of the class I MHC protein HLA-A2. Disulfide bonds are indicated as two connected spheres. The molecule is shown with the membrane proximal immunoglobulin-like domains (a3 and Pzm) at the bottom and the polymorphic al and a2 domains at the top. 

Figure 11.1 Schematic representation of a membrane separation unit...

FIGURE 18.5 Schematic representation of types of multienzyme systems carrying out a metabolic pathway (a) Physically separate, soluble enzymes with diffusing intermediates, (b) A multienzyme complex. Substrate enters the complex, becomes covalently bound and then sequentially modified by enzymes Ei to E5 before product is released. No intermediates are free to diffuse away, (c) A membrane-bound multienzyme system. 

Figure 2.17 Schematic representation of the set-up used for on-line liquid-liquid exti action coupled with capillary GC when using a membrane phase separator. Reprinted from Journal of High Resdution Chromatography, 13, E. C. Goosens et al., Determination of hexachloro-cyclohexanes in gi ound water by coupled liquid-liquid extraction and capillaiy gas cliro-matography , pp. 438-441, 1990, with permission from Wiley-VCH.

Feed solution Liquid membrane Receiving solution Fig. 5-1. Schematic representation of a liquid membrane for chiral separation. 

Fig. 5-10. Schematic representation of hollow-fiber membrane extraction.

Fig. 5-13. Schematic representation of the Akzo Nobel enantiomer separation process. Two liquids containing the opposing enantiomers of the chiral selector (FI and K) are flowing countercurrently through the column (4) and are kept separated by the liquid membrane (3). The racemic mixture to be separated is added to the middle of the system (1), and the separated enantiomers are recovered from the outflows of the column (2a and 2b) [64],...

Figure 7.10 Schematic representation of the apparatus for measuring osmotic pressure. The flow of solvent through the semipermeable membrane is followed by observing the movement of the meniscus of the flow indicator. The osmotic pressure II is the pressure that must be applied to the solution to prevent the flow.

FIGURE 6-15 Schematic representation of the ion permeability modulation for cation-responsive voltammetric sensors based on negatively charged lipid membranes. Complexation of the guest cation to the phospholipid receptors causes an increase of the permeability for the anionic marker ion. (Reproduced with permission from reference 49.)... 

Fig. 27 a and b. Schematic representation of the molecular structure of a side chain polymeric liquid crystals b polymer model membranes studied by 2H NMR... 

Figure 46-5. Variations in the way in which proteins are inserted into membranes. This schematic representation, which illustrates a number of possible orientations, shows the segments of the proteins within the membrane as a-helicesand the other segments as lines. The LDL receptor, which crosses the membrane once and has its amino terminal on the exterior, is called a type I transmembrane protein. The asialoglycoprotein receptor, which also crosses the membrane once but has its carboxyl terminal on the exterior, is called a type II transmembrane protein. The various transporters indicated (eg, glucose) cross the membrane a number of times and are called type III transmembrane proteins they are also referred to as polytopic membrane proteins. (N, amino terminal C, carboxyl terminal.) (Adapted, with permission, from Wickner WT, Lodish HF Multiple mechanisms of protein insertion into and across membranes. Science 1985 230 400. Copyright 1985 by the American Association for the Advancement of Science.)...

Figure 48-5. Schematic representation of fibronectin interacting with an integrin fibronectin receptor situated in the exterior of the plasma membrane of a cell of the ECM and of various attachment proteins interacting indirectly or directly with an actin microfilament in the cytosol. For simplicity, the attachment proteins are represented as a complex.

Fig. 2. Schematic representation of electrodes, (a) Content of Nafion too low not enough catalysts with ionic connection to membrane, (b) Optimal Nafion content electronic and ionic connections well balanced, (c) Content of Nafion too high catalyst particles electronically isolated from diflusion layer. Reproduced from [9].

Fig. 9.1 Schematic representation of possible mechanisms of resistance in Gram-negative and Gram-positive bacteria. 1, antibiotic-inactivating enzymes 2, antibiotic efflux proteins 3, alteration or duplication of intracellular targets 4, alteration of the cell membrane reducing antibiotic uptake 5, alterations in porins or lipopolysaccharide reducing antibiotic uptake or binding.

Figure 3.1 Schematic representation of a generic excitatory synapse in the brain. The presynaptic terminal releases the transmitter glutamate by fusion of transmitter vesicles with the nerve terminal membrane. Glutamate diffuses rapidly across the synaptic cleft to bind to and activate AMPA and NMDA receptors. In addition, glutamate may bind to metabotropic G-protein-coupled glutamate receptors located perisynaptically to cause initiation of intracellular signalling via the G-protein, Gq, to activate the enzyme phospholipase and hence produce inositol triphosphate (IP3) which can release Ca from intracellular calcium stores...

Figure 18.5 Schematic representation of possible cleavage sites of APP by a, and y-secretase and the production of j5-amyloid protein. (I) This shows the disposition of APP molecules in 695, 751 and 770 amino-acid chain lengths. Much of it is extracellular. The /1-amyloid (A/I4) sequence is partly extracellular and partly in the membrane. (II) An enlargement of the /1-amyloid sequence. (Ill) Normal cleavage of APP by a-secretase occurs in the centre of A/I4 sequence to release the extracellular APP while the remaining membrane and intracellular chain is broken down by y-secretase to give two short proteins that are quickly broken down. (IV) In Alzheimer s disease ji rather than a-secretase activity splits off the extracellular APP to leave the full AP4 sequence remaining attached to the residual membrane and intracellular chain. 42/43 amino acid )S-amyloid sequence is then split off by y-secretase activity...

Figure 3 is a schematic representation of a typical CO electrode. A KCI/HCOJ containing electrolyte solution is trapped within a nylon mesh spacer layer whose pH is monitored by a contacting conventional glass pH electrode. A CO permeable membrane isolates the electrolyte layer from the analyte phase. Currently available... 

Figure 9.23 Schematic representation of the various electrochemical and chemical reactions occurring in a membrane electrode assembly and the concentration gradients of O2, H2, and Pt ions. The location where the local O2 molar flux equals one-half of the local H2 molar flux is marked by 5pt. (Reproduced with permission from Zhang J et al. [2007a].)...

Figure 15.2 Schematic representation of different electrochemical cell types used in studies of electrocatalytic reactions (a) proton exchange membrane single cell, comprising a membrane electrode assembly (b) electrochemical cell with a gas diffusion electrode (c) electrochemical cell with a thin-layer working electrode (d) electrochemical cell with a model nonporous electrode. CE, counter-electrode RE, reference electrode WE, working electrode.

FIG. 10 Schematic representation of the proposed surface model (a) the concentration and (b) the electrical potential profiles at the interface of the membrane and aqueous sample solution, x = 0 and 0 are the positions of ions in the planes of closest approach (outer Helmholtz planes) from the aqueous and membrane sides, respectively. (From Ref. 17.)... 

Fig. 9 Schematic representation depicting the movement of molecules from the absorbing (mucosal or apical) surface of the GIT to the basolateral membrane and from there to blood. (A) transcellular movement through the epithelial cell. (B) Paracellular transport via movement between epithelial cells. (Q Specialized carrier-mediated transport into the epithelial cell. (D) Carrier-mediated efflux transport of drug out of the epithelial cell. (Copyright 2000 Saguaro Technical Press, Inc., used with permission.)...

Fig. 4 Schematic representation of a reservoir diffusional device. Cm(o) and Cm( represent concentrations of drug at inside surfaces of the membrane, and C(o) and C d) represent concentrations in the adjacent regions. (From Ref. 29.)...

Fig. 11 Schematic representation of liposome interactions at a membrane surface.

Schematic representation of the experimental setup is shown in Fig 1.1. The electrochemical system is coupled on-line to a Quadrupole Mass Spectrometer (Balzers QMS 311 or QMG 112). Volatile substances diffusing through the PTFE membrane enter into a first chamber where a pressure between 10 1 and 10 2 mbar is maintained by means of a turbomolecular pump. In this chamber most of the gases entering in the MS (mainly solvent molecules) are eliminated, a minor part enters in a second chamber where the analyzer is placed. A second turbo molecular pump evacuates this chamber promptly and the pressure can be controlled by changing the aperture between both chambers. Depending on the type of detector used (see below) pressures in the range 10 4-10 5 mbar, (for Faraday Collector, FC), or 10 7-10 9 mbar (for Secondary Electrton Multiplier, SEM) may be established.

Figure 2 Schematic representation of glucose-responsive polymer membrane constituted with polyamine membrane and glucose oxidase immobilized membrane. (From Ref. 20.)...

Figure 12 Schematic representation for reversibly changing drug permeation through membranes by external modulation. M, indicates the diffused amount of drug at time t. 

PM. The intense three peaks indicated by the grey in the top trace are ascribed to three Ala residues in the a-helix (helix G in this figure) protruding from the cytoplasmic membrane surface and four Ala residue in the C-terminal. (C) Schematic representation of the dynamic structure of bR in 2D crystal. The interfacial and kinked portions are illustrated by the shade and belts, respectively. From Refs. 22 and 179 with permission. 

Figure 11.1 Schematic representation of iron uptake mechanisms, (a) The transferrin-mediated pathway in animals involves receptor-mediated endocytosis of diferric transferrin (Tf), release of iron at the lower pH of the endocytic vesicle and recycling of apoTf. (b) The mechanism in H. influenzae involves extraction of iron from Tf at outer membrane receptors and transport to the inner membrane permease system by a periplasmic ferric binding protein (Fbp). From Baker, 1997. Reproduced by permission of Nature Publishing Group.

Fig. 14.1. Schematic representation of drug transport assay in cell monolayers cultured on a culture insert containing permeable membrane.

Fig. 1.16 Schematic representation of the nanofibrous poly (acrylonitrile-co-acrylic acid) membrane containing MWCNTs, as well as the promoted electron transfer from hydrogen peroxide to the immobilized catalase through the PANCAA/MWCNTs nanofiber. Reprinted from [209] (reproduced by permission ofWiley-VCH).

---